Corrigendum to 'Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands' [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011))

Autor: Evers, Jelle, Hendriks, Lizza E.L., De Jaeger, Katrien, Wijsman, Robin, De Ruysscher, Dirk, Terhaard, Chris, van der Sangen, Maurice, Siesling, Sabine, Struikmans, Henk, Aarts, Mieke J.
Přispěvatelé: TechMed Centre, Health Technology & Services Research
Jazyk: angličtina
Rok vydání: 2022
Zdroj: Lung cancer, 167, 107-107. Elsevier
ISSN: 0169-5002
Popis: The authors would like to inform that in the original publication two rows stating ‘RT alone’ in Table 1 were included, whereas only the upper row regards ‘RT alone’ and the lower row regards ‘Chemotherapy alone’. Also, the percentages of patients receiving stereotactic body radiotherapy (SBRT) were calculated with the number of patients receiving any radiotherapy (excl. prophylactic cranial irradiation (PCI)) as denominator, which may be unclear in the original publication. The authors would like to apologise for any inconvenience caused.
Databáze: OpenAIRE